Invitrogen Corporation (IVGN) and CytRx Laboratories, Inc. Subsidiary RXi Pharmaceuticals Collaborate to Enhance RNAi Technologies for Therapeutic Applications
11/14/2007 12:09:10 PM
More...
|
CytRx Laboratories, Inc. Reports Third Quarter 2007 Financial Results
11/14/2007 10:37:54 AM
More...
|
CytRx Laboratories, Inc. RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development
3/8/2007 12:15:50 PM
More...
|
CytRx Corporation (CYTR) Announces Scientific Data Showing The Potential Of Its Oral Drug, Arimoclomol, To Reverse Nerve Degeneration
10/19/2005 5:12:23 PM
More...
|
CytRx Corporation (CYTR) Two New Approaches With The Potential To Treat ALS
10/19/2005 5:12:22 PM
More...
|
CytRx Corporation's (CYTR) Subsidiary, Araios Inc., Changes Name To CytRx Laboratories, Inc.
10/19/2005 5:11:04 PM
More...
|
World-Renowned Scientist Joins Scientific Advisory Board Of CytRx Corporation (CYTR) Subsidiary, Araios Inc.
10/19/2005 5:09:29 PM
More...
|
Michael P. Czech, Ph.D., Chairman Of CytRx Laboratories, Inc. Scientific Advisory Board, Honored By American Diabetes Association
10/19/2005 5:08:59 PM
More...
|
CytRx Corporation (CYTR) Subsidiary Teams With 3rd Millennium Inc. For Scientific Computing Platform For RNAi-Based Diabetes And Obesity Drug Development
10/19/2005 5:08:53 PM
More...
|